Black Book Research Identifies Three Key Investment Signals in Healthcare IT

Black Book Research, a leading global healthcare technology market-research firm, has identified three underreported investment signals that could significantly influence the valuation, deal structure, and competitive positioning of healthcare IT companies through 2029. The findings, detailed in the Q3 2026 Healthcare IT Capital Signals report, shed light on emerging factors beyond the conventional focus on artificial intelligence (AI) and software.

The research, based on a survey of 119 professionals, including 50 capital-market and transaction specialists, 29 healthcare IT operating executives, and 40 provider and payer customers, highlights the importance of human infrastructure, transaction authority, and the convergence of the product stack and capital stack.

Firstly, the study reveals that human infrastructure is transforming into a strategic production capacity. Black Book found that while AI is reducing routine processing, it is simultaneously increasing the value of implementation specialists, workflow engineers, domain experts, and complex exception management personnel. Among transaction professionals, 64% indicated that specialized human infrastructure positively influenced valuation, transaction structure, or the willingness to proceed. Additionally, 60% of respondents stated that the transaction would have been significantly different without the implementation and operating workforce. Only 10% found the AI model or software itself to be the most difficult asset to replicate.

Doug Brown, the Founder of Black Book Research, explained, "AI is not eliminating the human layer so much as repricing it. Routine work is declining, but implementation expertise, workflow engineering, healthcare-domain knowledge, and complex exception management are becoming more strategically valuable."

Secondly, transaction authority is emerging as a critical permission-to-act moat. The report found that 68% of transaction professionals believed workflow write-back or execution authority positively influenced valuation or deal structure. When competing AI models were assumed to be equally capable, 68% selected platforms that could initiate, complete, settle, or guarantee transactions as holding the stronger position, while only 4% chose analytics-only platforms.

Brown noted, "The next healthcare technology moat may not be a better prediction. It may be the authority to submit, route, settle, or complete the transaction when competing platforms can only recommend what should happen."

Lastly, the report highlights the convergence of the product stack and capital stack. In selected healthcare IT categories, credit, liquidity, payment guarantees, and financial-risk capacity are becoming integral components of product delivery. Thirty-six percent of referenced transactions involved capital directly integrated into the customer-facing product. Among those applicable transactions, 83.3% reported a positive transaction effect, while 77.8% said the deal would have changed materially without the financing or risk structure.

Brown concluded, "When a healthcare platform requires credit capacity to deliver its customer promise, the capital stack has become part of the product. That changes valuation, scalability, regulatory exposure, and the diligence questions investors need to ask."

These findings suggest that as AI capabilities become more widely available, defensibility may increasingly shift towards the operating assets surrounding the model, including the people who operationalize it, the permissions that allow it to act, and the capital that enables it to finance or guarantee an outcome.

The report forecasts that through 2029, investors and strategic buyers will increasingly scrutinize implementation capacity, transaction rights, workflow control, capital dependence, and completed-outcome economics alongside traditional software metrics.